BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 20160039)

  • 1. Talin1 promotes tumor invasion and metastasis via focal adhesion signaling and anoikis resistance.
    Sakamoto S; McCann RO; Dhir R; Kyprianou N
    Cancer Res; 2010 Mar; 70(5):1885-95. PubMed ID: 20160039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Talin1 phosphorylation activates β1 integrins: a novel mechanism to promote prostate cancer bone metastasis.
    Jin JK; Tien PC; Cheng CJ; Song JH; Huang C; Lin SH; Gallick GE
    Oncogene; 2015 Apr; 34(14):1811-21. PubMed ID: 24793790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effect of the focal adhesion kinase Y397F mutant on v-Src-stimulated cell invasion and tumor growth.
    Chang LC; Huang CH; Cheng CH; Chen BH; Chen HC
    J Biomed Sci; 2005; 12(4):571-85. PubMed ID: 16132110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel pharmacologic targeting of tight junctions and focal adhesions in prostate cancer cells.
    Hensley PJ; Desiniotis A; Wang C; Stromberg A; Chen CS; Kyprianou N
    PLoS One; 2014; 9(1):e86238. PubMed ID: 24497940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prostate metastasis suppressor gene NDRG1 differentially regulates cell motility and invasion.
    Sharma A; Mendonca J; Ying J; Kim HS; Verdone JE; Zarif JC; Carducci M; Hammers H; Pienta KJ; Kachhap S
    Mol Oncol; 2017 Jun; 11(6):655-669. PubMed ID: 28371345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ORAI2 Promotes Gastric Cancer Tumorigenicity and Metastasis through PI3K/Akt Signaling and MAPK-Dependent Focal Adhesion Disassembly.
    Wu S; Chen M; Huang J; Zhang F; Lv Z; Jia Y; Cui YZ; Sun LZ; Wang Y; Tang Y; Verhoeft KR; Li Y; Qin Y; Lin X; Guan XY; Lam KO
    Cancer Res; 2021 Feb; 81(4):986-1000. PubMed ID: 33310726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of talin in cancer progression and metastasis.
    Desiniotis A; Kyprianou N
    Int Rev Cell Mol Biol; 2011; 289():117-47. PubMed ID: 21749900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting anoikis resistance in prostate cancer metastasis.
    Sakamoto S; Kyprianou N
    Mol Aspects Med; 2010 Apr; 31(2):205-14. PubMed ID: 20153362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Src activation regulates anoikis in human colon tumor cell lines.
    Windham TC; Parikh NU; Siwak DR; Summy JM; McConkey DJ; Kraker AJ; Gallick GE
    Oncogene; 2002 Nov; 21(51):7797-807. PubMed ID: 12420216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rad9 protein contributes to prostate tumor progression by promoting cell migration and anoikis resistance.
    Broustas CG; Zhu A; Lieberman HB
    J Biol Chem; 2012 Nov; 287(49):41324-33. PubMed ID: 23066031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Roles of Talin2 in Traction Force Generation, Tumor Metastasis and Cardiovascular Integrity.
    Qi L; Kolodziej T; Rajfur Z; Huang C
    Curr Protein Pept Sci; 2018; 19(11):1071-1078. PubMed ID: 30091412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anoikis disruption of focal adhesion-Akt signaling impairs renal cell carcinoma.
    Sakamoto S; Schwarze S; Kyprianou N
    Eur Urol; 2011 May; 59(5):734-44. PubMed ID: 21269758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. S100A16 promotes cell proliferation and metastasis via AKT and ERK cell signaling pathways in human prostate cancer.
    Zhu W; Xue Y; Liang C; Zhang R; Zhang Z; Li H; Su D; Liang X; Zhang Y; Huang Q; Liu M; Li L; Li D; Zhao AZ; Liu Y
    Tumour Biol; 2016 Sep; 37(9):12241-12250. PubMed ID: 27240591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulation of Talin1 promotes hepatocellular carcinoma progression through activation of the ERK1/2 pathway.
    Chen P; Lei L; Wang J; Zou X; Zhang D; Deng L; Wu D
    Cancer Sci; 2017 Jun; 108(6):1157-1168. PubMed ID: 28375585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RhoC promotes metastasis via activation of the Pyk2 pathway in prostate cancer.
    Iiizumi M; Bandyopadhyay S; Pai SK; Watabe M; Hirota S; Hosobe S; Tsukada T; Miura K; Saito K; Furuta E; Liu W; Xing F; Okuda H; Kobayashi A; Watabe K
    Cancer Res; 2008 Sep; 68(18):7613-20. PubMed ID: 18794150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting the Metastasis Suppressor, N-Myc Downstream Regulated Gene-1, with Novel Di-2-Pyridylketone Thiosemicarbazones: Suppression of Tumor Cell Migration and Cell-Collagen Adhesion by Inhibiting Focal Adhesion Kinase/Paxillin Signaling.
    Wangpu X; Lu J; Xi R; Yue F; Sahni S; Park KC; Menezes S; Huang ML; Zheng M; Kovacevic Z; Richardson DR
    Mol Pharmacol; 2016 May; 89(5):521-40. PubMed ID: 26895766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Talin1 regulates integrin turnover to promote embryonic epithelial morphogenesis.
    Liu J; He X; Qi Y; Tian X; Monkley SJ; Critchley DR; Corbett SA; Lowry SF; Graham AM; Li S
    Mol Cell Biol; 2011 Aug; 31(16):3366-77. PubMed ID: 21670148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral consumption of green tea polyphenols inhibits insulin-like growth factor-I-induced signaling in an autochthonous mouse model of prostate cancer.
    Adhami VM; Siddiqui IA; Ahmad N; Gupta S; Mukhtar H
    Cancer Res; 2004 Dec; 64(23):8715-22. PubMed ID: 15574782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Over-expression of lipocalin 2 promotes cell migration and invasion through activating ERK signaling to increase SLUG expression in prostate cancer.
    Ding G; Fang J; Tong S; Qu L; Jiang H; Ding Q; Liu J
    Prostate; 2015 Jun; 75(9):957-68. PubMed ID: 25728945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Constitutive activation of P I3 K-Akt and NF-kappaB during prostate cancer progression in autochthonous transgenic mouse model.
    Shukla S; Maclennan GT; Marengo SR; Resnick MI; Gupta S
    Prostate; 2005 Aug; 64(3):224-39. PubMed ID: 15712212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.